http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Dave Hickey Announces Intent to Retire from BD
-
BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore
-
BD to Present at Investor Healthcare Conferences
-
BD to Present Next Installment of BD Innovates Series: Spotlight on Peripheral Vascular Disease
-
BD Reports First Quarter Fiscal 2024 Financial Results
-
BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
-
BD Helps Advance Health Equity for Women in Kenya through Critical Cancer Screening
-
BD Board Declares Dividend
-
Becton Dickinson (BDX) and Hamilton Collaborate to Standardize Single-Cell Multiomics Experiments Using Robotics
-
BD, Hamilton Collaborate to Standardize Single-Cell Multiomics Experiments Using Robotics
-
New Survey by The Harris Poll Highlights Gaps in Cervical Cancer Screening Access
-
BD Announces Webcast of Annual Meeting of Shareholders
-
BD to Announce Financial Results for its First Quarter of Fiscal 2024
-
BD to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
BD Signs World Economic Forum's Zero Health Gaps Pledge
-
Becton Dickinson (BDX) gains FDA 510(k) clearance for novel blood collection device BD MiniDraw
-
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
-
BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems
-
FDA Safety Communication Does Not Impact BD Syringes
-
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
-
Becton Dickinson (BDX) Appoints Ronald Silverman as Chief Medical Officer
-
BD Names Dr. Ronald Silverman as Chief Medical Officer
-
BD to Present at the 6th Annual Evercore ISI HealthCONx Conference
-
BD Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
-
BD Board Increases Dividend for 52nd Consecutive Year
-
BD Advances "One-Stick Hospital Stay" Vision with Launch of Next-Generation Needle-Free Blood Draw Technology
-
BD Named Among the 100 Best Corporate Citizens of 2023
-
BD Names Greg Rodetis as Senior Vice President of Investor Relations
-
BD, Casella Complete Industry-First Pilot Recycling 40,000 Pounds of Used Medical Devices
-
BD, Casella Complete Industry-First Pilot Recycling 40,000 Pounds of Used Medical Devices
-
BD to Announce Fiscal 2023 Fourth Quarter and Full Year Financial Results
-
BD Ranks in Top 10 for Transparency, Awarded Best Code of Conduct in 2023 U.S. Transparency Awards
-
BD to Present at Investor Healthcare Conferences
-
BD Reports Third Quarter Fiscal 2023 Financial Results
-
BD (BDX) Granted 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
-
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
-
BD Board Declares Dividend
-
Becton Dickinson (BDX) Appoints Joanne Waldstreicher to its Board
-
BD Names Joanne Waldstreicher to Board of Directors
-
Becton Dickinson (BDX) granted FDA 510(k) clearance of BD Alaris Infusion System
-
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris™ Infusion System
-
BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System
-
BD Issues FY 2022 ESG Report, Highlights Notable Progress in Energy and Waste Reduction, Health Care Access and Diversity
-
BD Recognized as a Best Place to Work for Disability Inclusion
-
Becton Dickinson (BDX) to Sell Surgical Instrumentation Platform to STERIS (STE) for $540M
-
BD to Sell Surgical Instrumentation Platform to STERIS
-
Becton Dickinson (BDX) Launches New Robotic System to Automate Clinical Flow Cytometry
-
BD Launches New Robotic System to Automate Clinical Flow Cytometry
-
BD Advances Prefilled Flush Syringe with Integrated 'Scrub-the-Hub' Innovation
-
BD Launches World's First Spectral Cell Sorter with High-Speed Cell Imaging

